Infectious Diseases (except HIV/AIDS)
-
Immunogenicity and reactogenicity of an inactivated SARS-CoV-2 vaccine (BBV152) in children aged 2–18 years: interim data from an open-label, non-randomised, age de-escalation phase 2/3 study
This article has 14 authors:Reviewed by ScreenIT
-
Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection
This article has 13 authors:Reviewed by ScreenIT
-
Relationship between temperature and relative humidity on initial spread of COVID-19 cases and related deaths in Brazil
This article has 6 authors:Reviewed by ScreenIT
-
SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies
This article has 21 authors:Reviewed by ScreenIT
-
Quantitation of SARS-CoV-2 neutralizing antibodies with a virus-free, authentic test
This article has 13 authors:Reviewed by ScreenIT
-
Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
This article has 24 authors:Reviewed by ScreenIT
-
Method versatility in RNA extraction-free PCR detection of SARS-CoV-2 in saliva samples
This article has 10 authors:Reviewed by ScreenIT
-
SARS-CoV-2 Omicron Variant: Exploring Healthcare Workers' Awareness and Perception of Vaccine Effectiveness: A National Survey During the First Week of WHO Variant Alert
This article has 24 authors:Reviewed by ScreenIT
-
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
This article has 16 authors:Reviewed by ScreenIT
-
Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study
This article has 17 authors:Reviewed by ScreenIT